Welcome to the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference. We are dedicated to presenting the annual event that the life science industry can rely on for the latest thinking in clinical trials for 21st century drug development.
Insights into DPharm
DPharm 2015 Sessions
|Making Clinical Trials a Care
Option for Patients:
Piloting an Infrastructure
|Will the Mobile Phone be
|What Happens When a Rare
Disease Protocol is Co-Designed
by 250+ Patients and 60+ MDS?
|Andreas Koester, MD, PhD
VP, Clinical Trial Innovation & External Alliances
|Craig Lipset, MBA
Head of Clinical Innovation, R&D
It was a daunting task to develop the first industry forum on thinking radically differently about the way we perform clinical trials, but the result was this conference. The event was launched in September 2011 with 125 disruptive thinkers and change makers eager to discuss current solutions in clinical development, propose innovative changes, and commit to testing and sharing the results in order to transform drug development and the industry.
The first DPharm addressed virtual clinical trial models, adaptive design thinking, the role of EHRs in clinical data, open source, telemedicine, and self-reported patient data among many other ideas. I remember Dr Tomasz Sablinski, Founder, Transparency Life Sciences saying it was the first event he had attended in a long time where he did not leave feeling depressed.
By the time the 2nd annual DPharm program took place, the concept of applying disruptive thinking to clinical development had taken root, with many attendees bearing titles with clinical innovation in them. Fast forward to 2015, the 5th annual program addressed a jam packed agenda on the latest in innovative thinking to advance clinical trials. Not all innovation is disruptive, of course, but as a community, we can continue to drive change that helps bring down millions of dollars in clinical trials while greatly enhancing the patient experience to ultimately bring more drugs to those who need them most.
Radical Thinkers are Especially Welcomed for 2016
- This is a TED-style event showcasing innovations and leading practitioners in Pharma R&D with a focus on clinical research as well as innovative leaders from other industries.
- We strive to underscore the promise and challenge of innovation in advancing drug development.
- We strive to innovate a new model and find collaborations to get therapeutics to patients faster.
- We address how can we better apply the full spectrum of clinical research options and utilize insights more appropriately.
- We are dedicated to designing creative solutions and finding a way to implement them.
- We explore to whom are companies being disruptive and to gain a better understanding of the impact on clinical trials.
We are keeping the 2015 agenda up for your review. We are currently developing the 2016 agenda and look forward to sharing it with you shortly. You are welcome to contact us at firstname.lastname@example.org to share your thoughts and ideas for the 2016 event.
"I think Dpharm is the best conference of the year for clinical trial progress."
- Matthew Kirchoff, PharmD, USPHS FDA/CDER/Office of Medical Policy
"One of the most productive conferences for me in terms of getting innovative ideas, as well as meeting people of a disruptive nature, is The Conference Forum’s Disruptive Innovations To Advance Clinical Trials event."
- Robert Wright, Life Science Leader
"The Disruptive Innovation event to Advance Clinical Trials provides a vehicle that brings to light the many different ways companies/teams/individuals are accomplishing big and small innovations."
- Darshan Shah, AstraZeneca
"The Disruptive Innovations conference was a great experience for me as an academic cardiologist, trialist and global health researcher."
- Sameer Bansilal, MD, MS, Zena and Michael A Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
"It's really a pleasure to be part of what I am beginning to think may be the best industry conference for the money."
- Joseph Kim, Shire
"What’s great about the Disruptive Innovations conference is that it addresses all innovation ingredients."
- Rahlyn Gossen, Rebar Interactive
"Thank you. The DPharm and Global Clinical Trials events were outstanding. Your team have once again surpassed my expectations and delivered an event above and beyond anything else in the industry."
- Elan Josielewski, CRF Health
"Thank you for inviting me to an amazing experience. I am truly inspired and humbled by the incredible people that I met during the conference that are persevering through numerous obstacles to transform our industry. It makes me very hopeful that we will evolve and not be dinosaurs that become extinct."
- Komathi Stem, Genentech
"You put on a VERY professional meeting - congratulations!"
- Adrian McKemey, Quintiles
"Thanks for a great conference."
- Zen Chu, MIT
"My overall rating is A+! It was great and my brain was full by the time I boarded the plane to come home! Great for personal brainstorming and encouraging thinking out of the box."
- Susan Romberg, RPS
"It was a great journey to navigate across the innovative initiatives happening across the healthcare/lifescience industry."
- MaryAnne Rizk, PhD, Stevens Institute of Technology
"Overall,well organized and has a good spirit of innovation."
- Jerry Matczak, Eli Lilly
"Once again, let me tell you how much I enjoyed the conference. I took the ‘disruptive’ style of presentations at the meeting and adapted it to a presentation I gave to my colleagues in personalized medicine."
- Kiran Dole, PharmD, Novartis Institute for biomedical Research
"Great conference, wonderful presenters and topics and I especially liked the people featured from other industries."
- Caroline Manning, Merck
"Excellent conference. I would love to contribute and/or attend again. Great dialogue."
- Jeff Kingsley, SERRG
"Great networking opportunity."
- Brett Kleger, DrugDev
"Great conference, would come again! It was an awesome event! Exceeded my expectations. Venue was perfect and content was truly innovative."
- Marcella Lynch, Shire
"My colleague and I were last minute attendees at Dpharm, and we are so glad that we went. We felt at home among kindred spirits trying to accomplish something new, challenging, different, and disruptive."
- Brendan Kelleher, Karmadata
"Excellent! Real Disruption! Refreshing!"
- Thomas Krohn, Eli Lilly
"Kudos to the Conference Forum, Craig, John and Andreas for a truly fresh perspective on our industry. It has been very energizing and without tired topics. The format and content are top-notch and sophisticated. Well worth taking the time to attend."
- Deirdre BeVard, Endo Pharmaceuticals
"This conference was a very good mix of inspirational and specific nitty – gritty. WOW!"
- Veronica Ludensky, Takeda / Millenium
"Thank you! Excellent. The best conference I have attended in the last few years!"
- Maria Makarovskaya, Cubist Pharmaceuticals
"This was the first conference I attended in a very long time where I left feeling hopeful."
- Tomasz Sablinksi, MD, PhD, Celtic Therapeutics
"Information was new and fresh and the participants were all very eager to hear about innovations that could drive improvements in clinical trials - very interactive group within the meeting and the breaks. Great job organizing."
- Kathy Forde , Spaulding Clinical
"Extremely relevant, helpful and engaging."
- Tom Kaminski, Duke Clinical Research
"Wonderful insight into issues of innovation, well presented, excellent passionate talks."
- Michael Montgomery, Janssen Biotech
"Good presentations and presentation styles."
- Steven Najda, Roche